LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response

BACKGROUND: Clinically, only a minority of patients benefit from immunotherapy and few efficient biomarkers have been identified to distinguish patients who would respond to immunotherapy. The tumor microenvironment (TME) is reported to contribute to immunotherapy response, but details remain unknow...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jihong, Yuan, Lu, Huang, Wenqi, Liao, Liwei, Zhu, Xiaodi, Wang, Xiaoqing, Li, Jiaxin, Liang, Wenyu, Wu, Yuting, Liu, Xiaocheng, Yu, Dong, Zheng, Yunna, Guan, Jian, Zhan, Yongzhong, Liu, Laiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729252/
https://www.ncbi.nlm.nih.gov/pubmed/36505456
http://dx.doi.org/10.3389/fimmu.2022.1064874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729252/
https://www.ncbi.nlm.nih.gov/pubmed/36505456
http://dx.doi.org/10.3389/fimmu.2022.1064874

Ejemplares similares